ImmunXperts

ImmunXperts a Q² Solutions Company, provides immunogenicity risk assessment services, including in silico methods and in vitro methods like T cell activation/proliferation, cytokine release, MAPPS and pre-existing ADA Assays. The team also performs functional screening assays for drug candidates in immuno-oncology, auto-immunity, inflammation/infection, cell and gene therapy and other immune-related disease areas. Finally, our ImmunAcademy provides training, protocol review, assay transfer and PBMC network services.

For more information, please visit the ImmunXperts website